Evoq Therapeutics
About:
Evoq Therapeutics is a cancer immunotherapy company that provides disease-specific immune modulators.
Website: https://www.evoqtherapeutics.com/
Top Investors: National Institutes of Health
Description:
Evoq Therapeutics is a cancer immunotherapy company that provides disease-specific immune modulators to treat patients afflicted with autoimmune diseases. Its technology platform utilizes a proprietary NanoDisc that has been optimized to deliver antigens to restore immune tolerance.
Total Funding Amount:
$2M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Ann Arbor, Michigan, United States
Founded Date:
2016-01-01
Contact Email:
info(AT)evoqtherapeutics.com
Founders:
Anna Schwendeman, James Moon, William Brinkerhoff
Number of Employees:
1-10
Last Funding Date:
2024-08-29
IPO Status:
Private
Industries:
© 2025 bioDAO.ai